Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Journal of Surgical Oncology|June 8, 2018
Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumorsNina N Harke, Philipp Mandel, Jorn H Witt, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
European Urology Focus|April 15, 2021
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysisMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Journal of Surgical Oncology|June 8, 2018
Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumorsNina N Harke, Philipp Mandel, Jorn H Witt, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
European Urology Focus|April 15, 2021
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysisMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Pageof 23